Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
Alpha-methylated amphetamine analogue; norepinephrine releasing agent (1) ·
NMDA antagonist; fluorinated ketamine analogue (1) ·
'"`UNIQ--vote-000004C8-QINU`"' Largely hepatically cleared (~80% biliary); no active metabolite. Sacubitril-valsartan (Entresto) combines an ARB with neprilysin inhibition for HFrEF and was a notable advance over the ARB-alone trial (PARADIGM-HF, 2014)'"`UNIQ--ref-000004C9-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.


